Austria’s transformation of its R&D system over the last decade has attracted the attention of France, Spain and the Czech Republic, which are each following Austria’s model in hopes of attracting new R&D investments. This year, the country’s R&D spending as a percentage of GDP is expected to be 2.68%, compared to 1.8% 10 years […]
Washington, DC 12/18/08—BioTrove has withdrawn its IPO registration due to unfavorable market conditions. The company had planned to raise up to $75 million through the IPO (see IBO 4/15/08). BioTrove’s products include the OpenArray Solution system, which can perform thousands of PCR-based genomic analyses, and the RapidFire automated, sample preparation system for MS. Six-month sales […]
Lucerne, Switzerland 12/2/08—Following the sale of its Beverage business and the pending sale of its Real Estate business, Swiss-listed Eichhof Group AG will change its name to Datacolor AG, its Color Management business, early next year and become a dedicated supplier of colorimeters and other color management products (see IBO 8/15/08). The company has also […]
A meeting of the FDA’s Oncologic Drugs Advisory Committee earlier this month discussed the use of retrospective biomarker data in making regulatory decisions. Amgen and ImClone are seeking approval to include such data on drug labels. Amgen’s Vectibix and ImClone’s Erbitux are monoclonal antibodies used to treat colon cancer. Amgen is also seeking approval of […]
This year will be a period most investors would soon rather forget, as virtually all international stock markets suffered significant losses due to the current global economic crisis. For the year, the Dow Jones World Index fell approximately 43%, despite international efforts to lower interest rates and increase spending through massive bailout plans. The credit […]
R&D spending in Singapore increased 26.5% to SGD 6,339 million ($4,370 million), or 2.61% of GDP, according to a survey by the Agency for Science, Technology and Research (A*STAR). Experimental development, applied research and basic research accounted for 58%, 25% and 17% of R&D expenditures, respectively. Engineering and technology represented 65% of R&D expenditures, while […]
At the beginning of the month, the California Institute for Regenerative Medicine (CIRM) announced its first Tools and Technologies Awards. Established in 2004 as the result of the passage of a California ballot proposition, the nonprofit CIRM is charged with distributing $3 billion in loans and grants for stem cell research to public and private […]
Company Announcements FEI and Max Planck Institute of Biochemistry are collaborating on a correlative microscopy solution for the acquisition of TEM images of molecular entities found using optical microscopy techniques. In August, Intellection promoted CFO/COO Chris Staples to CEO. In November, Carl Zeiss opened a subsidiary for its Industrial Metrology business in Istanbul, Turkey, in […]
As IBO reported in its November 30 issue, Agilent Technologies’ Bio-Analytical Measurement business (BAM) revenues grew 14% in fiscal 2008 ended October 31 to $2,295 million. From the recent filing of SEC documents for the fiscal year, additional information is now available about the business’s fiscal year. Excluding acquisitions, which contributed 2% growth, and the […]
London, UK 12/8/08—Scientific Digital Imaging has listed on the London Stock Exchanges’s Alternative Investment Market (see IBO 11/30/08). The company issued 16,663,842 shares. The opening price was 12.5 pence ($0.18) per share, and the closing price at month end was at 11.75 pence ($0.17) per share. The company’s market capitalization is £2 million ($3 million).
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
